Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. India Urology Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Drug Class (Anticholinergic/ Antispasmodic Agents, Skeletal Muscle Relaxants, Alpha Blockers, Others)
5.2.2. By Type (Original Drugs v/s Generic Drugs)
5.2.3. By Application (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary Incontinence, Kidney/Bladder Stone, Erectile Dysfunction, Others)
5.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)
5.2.5. By Region (North India, South India, East India, West India)
5.2.6. By Company
5.3. Product Market Map

6. India Anticholinergic/ Antispasmodic Urology Agents Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Distribution Channel

7. India Skeletal Muscle Relaxants Urology Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Distribution Channel

8. India Alpha Blockers Urology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Distribution Channel

9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Merger & Acquisition
10.2. Product Development
10.3. Recent Developments
11. Policy & Regulatory Landscape
12. Porters Five Forces Analysis
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Products
13. India Economic Profile
14. Pricing Analysis
15. Competitive Landscape
15.1. Astellas Pharma India Pvt Ltd
15.2. Endo Pharmaceuticals
15.3. Sanofi India
15.4. Pfizer Ltd.
15.5. Innovexia Lifesciences
15.6. Salvus Pharma
15.7. Silhos Pharma Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer